DCTD Programs
Last Updated: 12/12/2024
DCTD’s Translational Research Program (TRP) Announces Fiscal Year 2024 SPORE Grantees
The TRP recently announced its successfully competed FY2024 Specialized Programs of Research Excellence (SPORE) grantees.
The SPORE program uses the P50 and U54 grant funding mechanisms to promote collaborative, interdisciplinary, translational cancer multi-project research. SPOREs are primarily focused on organ site disease, but also on themes that cut across organ sites.
There are now 56 funded SPOREs located at academic centers in 21 states. See information about all SPOREs by organ site and by state.
FY 2024 SPORE Grantees
| Principal Investigator | Institution | Cancer Type |
|---|---|---|
| Tracy T. Batchelor | Brigham and Women’s Hospital | Brain* |
| Frederick F. Lang; Juan Fueyo | University of Texas MD Anderson Cancer Center | Brain* |
| Charles M. Perou; Lisa A. Carey | University of North Carolina, Chapel Hill | Breast* |
| T-C Wu; Warner King Huh | Johns Hopkins University | Cervical* |
| Ulrike Peters; Christopher I. Li; Timothy Thomas | Fred Hutchinson Cancer Center | Cancer Health Disparities |
| Daniel C. Link | Washington University, St. Louis | Leukemia* |
| Mark A. McNiven; Lewis R. Roberts | Mayo Clinic, Rochester | Liver* |
| Ming-IE Shih; Ronny I. Drapkin | Johns Hopkins University | Ovarian* |
| Eric J. Small | University of California, San Francisco | Prostate |
| Samuel R. Denmeade; Shawn Lupold | Johns Hopkins University | Prostate |
| Samuel Singer | Memorial Sloan Kettering Cancer Center | Sarcoma* |
*Grant Renewal
Goals of the SPORE Program
- Translating novel scientific discoveries from the laboratory and/or population studies to the clinic for testing in humans with cancer or at risk for cancer
- Determining the biological basis for clinical observations
- Using specimens from clinical studies to determine correlations between biomarkers and outcomes in patients
- Promoting collaborations between SPOREs, Cancer Centers, other NCI/NIH funded mechanisms and programs, and outside organizations
- Promoting pilot projects and career enhancement of researchers new to translational research
- Supporting research in high incidence and rare cancers
- Encouraging communication with advocates and advocate organizations to obtain advice from the patient perspective
Contact TRP staff for more information on the SPORE program.